No Data
Japan Post, upward revision on March 25, ordinary profit 810 billion yen, down from 760 billion yen.
Japan Post <6178> announced a revision of its financial estimates for the fiscal year ending March 2025. The ordinary profit was revised upwards from 760 billion yen to 810 billion yen. While the profit estimates for the five postal banks <7182> and Japan Post Insurance <7181> will be revised upwards in November 2024 due to improved operating conditions and increased Asset Management revenue, the consolidated financial estimates for the full year are uncertain, particularly regarding the impact on future profits and losses from the upcoming postal rate revision at its consolidated subsidiary, Japan Post.
Wakamoto Pharmaceutical: Notice regarding revisions to earnings forecasts
Wakamoto Pharmaceutical Sees FY Parent Pretax Loss Y407.00M
The shareholding percentage of Wakamoto and Asset Value has increased to 8.54%.
It has been revealed that the shareholding ratio of Asset Value Investors (Asset Value) in Wakamoto <4512.T> has increased. According to the large shareholding change report submitted by Asset Value after the market closed on the 1st, the shareholding ratio rose from 7.45% at the time of the last submission to 8.54%. The purpose of the shareholding is to engage in pure investment and significant proposal activities, etc. The closing price on the 1st was 312 yen, down 5 yen from the previous day. Provided by Wealth Advisor Inc.
Express News | 【Change Report】Asset Value Investors Limited reported an increase in Shareholding in Wakamon Pharmaceuticals (4512.JP) to 8.54%.
Wakamoto Pharmaceutical To Go Ex-Dividend On March 28th, 2025 With 3 JPY Dividend Per Share
March 26th (Japan Standard Time) - $Wakamoto Pharmaceutical(4512.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 3 JPY dividend per share. The
